St. Jude Eyes Possible Acquisition Of Heart Failure Monitor Firm CardioMEMS

St. Jude Medical is placing a $60 million bet on wireless implantable heart failure monitor developer CardioMEMS and has acquired an exclusive option to own the entire company via a Sept. 7 agreement

More from Archive

More from Medtech Insight